ID   PLOD1_HUMAN             Reviewed;         727 AA.
AC   Q02809; B4DR87; Q96AV9; Q9H132;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2005, sequence version 2.
DT   10-MAY-2017, entry version 195.
DE   RecName: Full=Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1;
DE            EC=1.14.11.4 {ECO:0000250|UniProtKB:P24802};
DE   AltName: Full=Lysyl hydroxylase 1;
DE            Short=LH1;
DE   Flags: Precursor;
GN   Name=PLOD1; Synonyms=LLH, PLOD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 19-28 AND
RP   332-34, AND VARIANT THR-99.
RC   TISSUE=Placenta;
RX   PubMed=1577494; DOI=10.1016/0888-7543(92)90202-4;
RA   Hautala T., Byers M.G., Eddy R.L., Shows T.B., Kivirikko K.I.,
RA   Myllylae R.;
RT   "Cloning of human lysyl hydroxylase: complete cDNA-derived amino acid
RT   sequence and assignment of the gene (PLOD) to chromosome 1p36.3-
RT   p36.2.";
RL   Genomics 13:62-69(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7713497; DOI=10.1006/geno.1994.1654;
RA   Heikkinen J., Hautala T., Kivirikko K.I., Myllylae R.;
RT   "Structure and expression of the human lysyl hydroxylase gene (PLOD):
RT   introns 9 and 16 contain Alu sequences at the sites of recombination
RT   in Ehlers-Danlos syndrome type VI patients.";
RL   Genomics 24:464-471(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   THR-99 AND SER-120.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   MUTAGENESIS.
RX   PubMed=8621606; DOI=10.1074/jbc.271.16.9398;
RA   Pirskanen A., Kaimio A.M., Myllylae R., Kivirikko K.I.;
RT   "Site-directed mutagenesis of human lysyl hydroxylase expressed in
RT   insect cells. Identification of histidine residues and an aspartic
RT   acid residue critical for catalytic activity.";
RL   J. Biol. Chem. 271:9398-9402(1996).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   VARIANTS EDS6 GLU-532 DEL AND ARG-678.
RX   PubMed=8163671; DOI=10.1172/JCI117155;
RA   Ha V.T., Marshall M.K., Elsas L.J., Pinnell S.R., Yeowell H.N.;
RT   "A patient with Ehlers-Danlos syndrome type VI is a compound
RT   heterozygote for mutations in the lysyl hydroxylase gene.";
RL   J. Clin. Invest. 93:1716-1721(1994).
RN   [11]
RP   VARIANT EDS6 CYS-612.
RX   PubMed=9617436; DOI=10.1007/s004030050287;
RA   Brinckmann J., Acil Y., Feshchenko S., Katzer E., Brenner R.,
RA   Kulozik A., Kugler S.;
RT   "Ehlers-Danlos syndrome type VI: lysyl hydroxylase deficiency due to a
RT   novel point mutation (W612C).";
RL   Arch. Dermatol. Res. 290:181-186(1998).
RN   [12]
RP   VARIANT EDS6 367-ASP--GLN-371 DEL, AND MUTAGENESIS OF CYS-369.
RX   PubMed=10686424; DOI=10.1016/S0945-053X(99)00055-4;
RA   Yeowell H.N., Allen J.D., Walker L.C., Overstreet M.A., Murad S.,
RA   Thai S.F.;
RT   "Deletion of cysteine 369 in lysyl hydroxylase 1 eliminates enzyme
RT   activity and causes Ehlers-Danlos syndrome type VI.";
RL   Matrix Biol. 19:37-46(2000).
RN   [13]
RP   INVOLVEMENT IN EDS6.
RX   PubMed=15666309; DOI=10.1002/ajmg.a.30529;
RA   Giunta C., Randolph A., Al-Gazali L.I., Brunner H.G., Kraenzlin M.E.,
RA   Steinmann B.;
RT   "Nevo syndrome is allelic to the kyphoscoliotic type of the Ehlers-
RT   Danlos syndrome (EDS VIA).";
RL   Am. J. Med. Genet. A 133:158-164(2005).
RN   [14]
RP   VARIANT EDS6 GLY-446.
RX   PubMed=15854030; DOI=10.1111/j.0022-202X.2005.23727.x;
RA   Walker L.C., Overstreet M.A., Siddiqui A., De Paepe A., Ceylaner G.,
RA   Malfait F., Symoens S., Atsawasuwan P., Yamauchi M., Ceylaner S.,
RA   Bank R.A., Yeowell H.N.;
RT   "A novel mutation in the lysyl hydroxylase 1 gene causes decreased
RT   lysyl hydroxylase activity in an Ehlers-Danlos VIA patient.";
RL   J. Invest. Dermatol. 124:914-918(2005).
RN   [15]
RP   VARIANTS EDS6 THR-667 AND ARG-706.
RX   PubMed=15979919; DOI=10.1016/j.ymgme.2005.04.014;
RA   Giunta C., Randolph A., Steinmann B.;
RT   "Mutation analysis of the PLOD1 gene: an efficient multistep approach
RT   to the molecular diagnosis of the kyphoscoliotic type of Ehlers-Danlos
RT   syndrome (EDS VIA).";
RL   Mol. Genet. Metab. 86:269-276(2005).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] HIS-123.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Forms hydroxylysine residues in -Xaa-Lys-Gly- sequences
CC       in collagens. These hydroxylysines serve as sites of attachment
CC       for carbohydrate units and are essential for the stability of the
CC       intermolecular collagen cross-links.
CC       {ECO:0000250|UniProtKB:P24802}.
CC   -!- CATALYTIC ACTIVITY: L-lysine-[procollagen] + 2-oxoglutarate + O(2)
CC       = (2S,5R)-5-hydroxy-L-lysine-[procollagen] + succinate + CO(2).
CC       {ECO:0000250|UniProtKB:P24802}.
CC   -!- COFACTOR:
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033;
CC         Evidence={ECO:0000250|UniProtKB:P24802};
CC   -!- COFACTOR:
CC       Name=L-ascorbate; Xref=ChEBI:CHEBI:38290;
CC         Evidence={ECO:0000250|UniProtKB:P24802};
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P24802}.
CC   -!- SUBCELLULAR LOCATION: Rough endoplasmic reticulum membrane;
CC       Peripheral membrane protein; Lumenal side.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q02809-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q02809-2; Sequence=VSP_056300;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Ehlers-Danlos syndrome 6 (EDS6) [MIM:225400]: A
CC       connective tissue disorder characterized by generalized joint
CC       hypermobility, hyperextensible skin, atrophic cutaneous scars due
CC       to tissue fragility, progressive kyphoscoliosis already present at
CC       birth, ocular manifestations, arterial rupture, easy bruising,
CC       severe neonatal muscle hypotonia and delayed motor development.
CC       {ECO:0000269|PubMed:10686424, ECO:0000269|PubMed:15666309,
CC       ECO:0000269|PubMed:15854030, ECO:0000269|PubMed:15979919,
CC       ECO:0000269|PubMed:8163671, ECO:0000269|PubMed:9617436}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L06419; AAA60116.1; -; mRNA.
DR   EMBL; AF490527; AAM12752.1; -; Genomic_DNA.
DR   EMBL; AF490514; AAM12752.1; JOINED; Genomic_DNA.
DR   EMBL; AF490515; AAM12752.1; JOINED; Genomic_DNA.
DR   EMBL; AF490516; AAM12752.1; JOINED; Genomic_DNA.
DR   EMBL; AF490517; AAM12752.1; JOINED; Genomic_DNA.
DR   EMBL; AF490518; AAM12752.1; JOINED; Genomic_DNA.
DR   EMBL; AF490519; AAM12752.1; JOINED; Genomic_DNA.
DR   EMBL; AF490520; AAM12752.1; JOINED; Genomic_DNA.
DR   EMBL; AF490521; AAM12752.1; JOINED; Genomic_DNA.
DR   EMBL; AF490522; AAM12752.1; JOINED; Genomic_DNA.
DR   EMBL; AF490523; AAM12752.1; JOINED; Genomic_DNA.
DR   EMBL; AF490524; AAM12752.1; JOINED; Genomic_DNA.
DR   EMBL; AF490525; AAM12752.1; JOINED; Genomic_DNA.
DR   EMBL; AF490526; AAM12752.1; JOINED; Genomic_DNA.
DR   EMBL; AK299150; BAG61199.1; -; mRNA.
DR   EMBL; AK316285; BAH14656.1; -; mRNA.
DR   EMBL; AL096840; CAC19722.1; -; Genomic_DNA.
DR   EMBL; BC016657; AAH16657.1; -; mRNA.
DR   CCDS; CCDS142.1; -. [Q02809-1]
DR   PIR; A38206; A38206.
DR   RefSeq; NP_000293.2; NM_000302.3. [Q02809-1]
DR   RefSeq; NP_001303249.1; NM_001316320.1. [Q02809-2]
DR   UniGene; Hs.75093; -.
DR   ProteinModelPortal; Q02809; -.
DR   SMR; Q02809; -.
DR   BioGrid; 111366; 75.
DR   IntAct; Q02809; 25.
DR   MINT; MINT-1134973; -.
DR   STRING; 9606.ENSP00000196061; -.
DR   DrugBank; DB00139; Succinic acid.
DR   DrugBank; DB00126; Vitamin C.
DR   iPTMnet; Q02809; -.
DR   PhosphoSitePlus; Q02809; -.
DR   SwissPalm; Q02809; -.
DR   BioMuta; PLOD1; -.
DR   DMDM; 78099790; -.
DR   EPD; Q02809; -.
DR   MaxQB; Q02809; -.
DR   PaxDb; Q02809; -.
DR   PeptideAtlas; Q02809; -.
DR   PRIDE; Q02809; -.
DR   Ensembl; ENST00000196061; ENSP00000196061; ENSG00000083444. [Q02809-1]
DR   GeneID; 5351; -.
DR   KEGG; hsa:5351; -.
DR   UCSC; uc001atm.4; human. [Q02809-1]
DR   CTD; 5351; -.
DR   DisGeNET; 5351; -.
DR   GeneCards; PLOD1; -.
DR   GeneReviews; PLOD1; -.
DR   HGNC; HGNC:9081; PLOD1.
DR   HPA; HPA049137; -.
DR   HPA; HPA055799; -.
DR   MalaCards; PLOD1; -.
DR   MIM; 153454; gene.
DR   MIM; 225400; phenotype.
DR   neXtProt; NX_Q02809; -.
DR   OpenTargets; ENSG00000083444; -.
DR   Orphanet; 1900; Ehlers-Danlos syndrome, kyphoscoliotic type.
DR   PharmGKB; PA33411; -.
DR   eggNOG; KOG1971; Eukaryota.
DR   eggNOG; ENOG410Y4QU; LUCA.
DR   GeneTree; ENSGT00550000074427; -.
DR   HOGENOM; HOG000231099; -.
DR   HOVERGEN; HBG053618; -.
DR   InParanoid; Q02809; -.
DR   KO; K00473; -.
DR   OMA; IRQQDVF; -.
DR   OrthoDB; EOG091G02DK; -.
DR   PhylomeDB; Q02809; -.
DR   TreeFam; TF313826; -.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   ChiTaRS; PLOD1; human.
DR   GenomeRNAi; 5351; -.
DR   PRO; PR:Q02809; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000083444; -.
DR   CleanEx; HS_PLOD1; -.
DR   ExpressionAtlas; Q02809; baseline and differential.
DR   Genevisible; Q02809; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0030867; C:rough endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW.
DR   GO; GO:0008475; F:procollagen-lysine 5-dioxygenase activity; IDA:CAFA.
DR   GO; GO:0042803; F:protein homodimerization activity; TAS:UniProtKB.
DR   GO; GO:0006464; P:cellular protein modification process; NAS:UniProtKB.
DR   GO; GO:0008544; P:epidermis development; IMP:UniProtKB.
DR   GO; GO:0046947; P:hydroxylysine biosynthetic process; IDA:CAFA.
DR   GO; GO:0055114; P:oxidation-reduction process; TAS:UniProtKB.
DR   GO; GO:0017185; P:peptidyl-lysine hydroxylation; IDA:CAFA.
DR   GO; GO:0001666; P:response to hypoxia; IEP:UniProtKB.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR005123; Oxoglu/Fe-dep_dioxygenase.
DR   InterPro; IPR006620; Pro_4_hyd_alph.
DR   InterPro; IPR001006; Procol_lys_dOase.
DR   Pfam; PF03171; 2OG-FeII_Oxy; 1.
DR   SMART; SM00702; P4Hc; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS51471; FE2OG_OXY; 1.
DR   PROSITE; PS01325; LYS_HYDROXYLASE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Dioxygenase;
KW   Direct protein sequencing; Disease mutation; Ehlers-Danlos syndrome;
KW   Endoplasmic reticulum; Glycoprotein; Iron; Membrane; Metal-binding;
KW   Oxidoreductase; Polymorphism; Reference proteome; Signal; Vitamin C.
FT   SIGNAL        1     18       {ECO:0000269|PubMed:1577494}.
FT   CHAIN        19    727       Procollagen-lysine,2-oxoglutarate 5-
FT                                dioxygenase 1.
FT                                /FTId=PRO_0000024678.
FT   DOMAIN      636    727       Fe2OG dioxygenase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00805}.
FT   ACT_SITE    718    718       {ECO:0000255}.
FT   METAL       656    656       Iron.
FT   METAL       658    658       Iron.
FT   METAL       708    708       Iron.
FT   CARBOHYD    163    163       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    197    197       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305}.
FT   CARBOHYD    538    538       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305}.
FT   CARBOHYD    686    686       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ      25     25       E -> EAPCCQEGLRAGGSGSLHLGRDFTVLAGARGSPSPS
FT                                VSSIPRFWIPGS (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056300.
FT   VARIANT      67     67       E -> D (in dbSNP:rs7551068).
FT                                /FTId=VAR_032754.
FT   VARIANT      84     84       A -> T (in dbSNP:rs34878020).
FT                                /FTId=VAR_032755.
FT   VARIANT      99     99       A -> T (in dbSNP:rs7551175).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:1577494}.
FT                                /FTId=VAR_014220.
FT   VARIANT     120    120       A -> S (in dbSNP:rs2273285).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_032756.
FT   VARIANT     123    123       Q -> H (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035479.
FT   VARIANT     367    371       Missing (in EDS6).
FT                                {ECO:0000269|PubMed:10686424}.
FT                                /FTId=VAR_009269.
FT   VARIANT     446    446       W -> G (in EDS6).
FT                                {ECO:0000269|PubMed:15854030}.
FT                                /FTId=VAR_023466.
FT   VARIANT     532    532       Missing (in EDS6).
FT                                {ECO:0000269|PubMed:8163671}.
FT                                /FTId=VAR_006354.
FT   VARIANT     612    612       W -> C (in EDS6; dbSNP:rs121913553).
FT                                {ECO:0000269|PubMed:9617436}.
FT                                /FTId=VAR_006355.
FT   VARIANT     667    667       A -> T (in EDS6; dbSNP:rs199730384).
FT                                {ECO:0000269|PubMed:15979919}.
FT                                /FTId=VAR_023467.
FT   VARIANT     678    678       G -> R (in EDS6; dbSNP:rs121913551).
FT                                {ECO:0000269|PubMed:8163671}.
FT                                /FTId=VAR_006356.
FT   VARIANT     706    706       H -> R (in EDS6).
FT                                {ECO:0000269|PubMed:15979919}.
FT                                /FTId=VAR_023468.
FT   MUTAGEN     369    369       C->A: Loss of activity.
FT                                {ECO:0000269|PubMed:10686424}.
SQ   SEQUENCE   727 AA;  83550 MW;  6C3E0C11B15D598C CRC64;
     MRPLLLLALL GWLLLAEAKG DAKPEDNLLV LTVATKETEG FRRFKRSAQF FNYKIQALGL
     GEDWNVEKGT SAGGGQKVRL LKKALEKHAD KEDLVILFAD SYDVLFASGP RELLKKFRQA
     RSQVVFSAEE LIYPDRRLET KYPVVSDGKR FLGSGGFIGY APNLSKLVAE WEGQDSDSDQ
     LFYTKIFLDP EKREQINITL DHRCRIFQNL DGALDEVVLK FEMGHVRARN LAYDTLPVLI
     HGNGPTKLQL NYLGNYIPRF WTFETGCTVC DEGLRSLKGI GDEALPTVLV GVFIEQPTPF
     VSLFFQRLLR LHYPQKHMRL FIHNHEQHHK AQVEEFLAQH GSEYQSVKLV GPEVRMANAD
     ARNMGADLCR QDRSCTYYFS VDADVALTEP NSLRLLIQQN KNVIAPLMTR HGRLWSNFWG
     ALSADGYYAR SEDYVDIVQG RRVGVWNVPY ISNIYLIKGS ALRGELQSSD LFHHSKLDPD
     MAFCANIRQQ DVFMFLTNRH TLGHLLSLDS YRTTHLHNDL WEVFSNPEDW KEKYIHQNYT
     KALAGKLVET PCPDVYWFPI FTEVACDELV EEMEHFGQWS LGNNKDNRIQ GGYENVPTID
     IHMNQIGFER EWHKFLLEYI APMTEKLYPG YYTRAQFDLA FVVRYKPDEQ PSLMPHHDAS
     TFTINIALNR VGVDYEGGGC RFLRYNCSIR APRKGWTLMH PGRLTHYHEG LPTTRGTRYI
     AVSFVDP
//
